Article

Congress awaits approval of eye trauma measure for injured active-duty service members

Washington, DC-Congress is awaiting presidential approval of legislation designed to improve the ability of the Department of Defense (DoD) and the Veterans Health Administration to treat members of the military who have suffered serious eye injuries while on active duty.

Washington, DC-Congress is awaiting presidential approval of legislation designed to improve the ability of the Department of Defense (DoD) and the Veterans Health Administration to treat members of the military who have suffered serious eye injuries while on active duty.

The legislation, which Congress passed as part of the National Defense Authorization Act, would establish a Center of Excellence within the DoD to improve the tracking, diagnosis, treatment, and follow-up for service members who have incurred eye injuries. It also would create a formal registry that would house electronic records and enable the DoD and Department of Veterans Affairs to share patient information. The measure passed by Congress does not provide for funding for the center or registry, however.

The legislation was presented to President George W. Bush Dec. 19, but Dec. 28 he announced that he was withholding approval.

The American Academy of Ophthalmology has joined the Blinded Veterans Association and other veterans’ service organizations in support of the legislation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.